For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research ...
New guidelines that seek to change how asthma is treated in Australia have been unveiled by Health Minister Mark Butler and the National Asthma Council of Australia (NAC).
Discover a study showing budesonide–formoterol cuts childhood asthma attacks by 45%, offering a safer alternative to ...
The National Asthma Council’s advice for treating the condition has been updated, advising doctors against solely prescribing blue puffers to patients.
Among pediatric patients with intermittent asthma, around one-third did not have significant acute care needs over a 2-year ...
A joint scientific study conducted by researchers at the Medical Research Institute of New Zealand, in collaboration with ...
A pediatric asthma subgroup at high risk for acute respiratory infections can be identified using 2 natural language processing algorithms.
A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the ...
Children with mild asthma at low risk for severe exacerbations may not need daily or as-needed ICS, as GINA guidelines recommend.
"Asthma Pipeline Insights"DelveInsight's,“Asthma - Pipeline Insight, 2025,” report provides comprehensive insights about 80+ companies and 90+ pipeline drugs in Asthma pipeline landscape. It covers ...
Findings could redefine the treatment for millions of children worldwide with asthma, after this comparison of two types of asthma inhalers.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback